Fresenius | FRE - Operating Profit


Fresenius reported EUR713M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Akzo Nobel EUR 254M 37M Mar/2026
Alcon AG USD 297M 16M Mar/2026
AstraZeneca USD 7.11B 4.14B Mar/2026
BASF EUR 1.4B 1.58B Mar/2026
Bayer EUR 3.53B 2.42B Mar/2026
Beiersdorf EUR 504M 312M Dec/2025
DaVita Healthcare Partners USD 473.55M 110.66M Mar/2026
Demant DKK 2.09B 224M Dec/2025
E.ON EUR 4.11B 3.05B Mar/2026
Essilor EUR 1.38B 626M Dec/2025
Fresenius EUR 713M 139M Dec/2025
Fresenius Medical Care EUR 268M 395M Mar/2026
Getinge SEK 1.08B 900M Dec/2024
Givaudan CHF 610M 149M Dec/2025
GlaxoSmithKline GBP 2.29B 856M Mar/2026
GN Store Nord DKK -68M 638M Mar/2026
GRIFOLS EUR 249M 26.38M Mar/2026
Hikma Pharmaceutical USD 348M 161M Dec/2025
Lonza CHF 673M 243M Jun/2025
Merck EUR 1.05B 572M Mar/2026
Novartis USD 4.24B 171M Mar/2026
Philips EUR 302M 417M Mar/2026
Roche Holding CHF 9.56B 3.8B Dec/2025
RWE EUR -139M 716M Mar/2026
Sanofi EUR 1.94B 239M Mar/2026
Smith & Nephew USD 440M 50M Dec/2025